Modified Vaccinia Ankara: Potential as an Alternative Smallpox Vaccine

McCurdy, Lewis H.; Larkin, Brenda D.; Martin, Julie E.; Graham, Barney S.
June 2004
Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1749
Academic Journal
Despite the declaration of smallpox eradication in 1980, the existence of variola stockpiles and the threat of bioterrorism demand that immunity to smallpox through vaccination be maintained. Although the currently available vaccine was used for the most successful medical intervention ever accomplished, it also is associated with side effects that are difficult to accept in a vaccine for a disease that has not been present for >25 years. Herein, we review alternative approaches to maintaining immunity to smallpox through vaccination with attenuated poxviruses, and we suggest modified vaccinia Ankara (MVA) as a leading candidate for an alternative smallpox vaccine.


Related Articles

  • Smallpox Bioterrorism Attacks Could Spell Trouble Despite Vaccine.  // Emergency Preparedness News;Jun2009, Vol. 33 Issue 6, p3 

    The article reports on the medical study undertaken by Dr. Martin Eichner and colleagues from the University of Tuebingen in Germany concerning smallpox vaccinations. According to the medical report, people who received primary smallpox vaccination are protected against smallpox for decades and...

  • What should we do about smallpox Immunization?  // Contemporary Pediatrics;Nov2002, Vol. 19 Issue 11, p13 

    Explores issues concerning smallpox immunization in the U.S. Reason behind the plans for mass immunization in the country; Remarks from Julie Gerberding, appointed director of the U.S. Centers for Disease Control & Prevention; Adverse effects of smallpox vaccination.

  • smallpox vaccine.  // Royal Society of Medicine: Medicines;2002, p498 

    The article provides information on a smallpox vaccine which consists of a suspension of live viruses. Smallpox vaccine also works against other poxes and is still used in specialist centres by researchers who work there with dangerous viruses, so need to be immunized. Also, the vaccine is now...

  • Smallpox vaccination advice. Hoey, John // CMAJ: Canadian Medical Association Journal;11/12/2002, Vol. 167 Issue 10, p1148 

    Offers advice on smallpox vaccination. Discusses impact of smallpox virus if obtained by terrorists for use as a biological weapon; How smallpox is transmitted; Questions whether smallpox vaccination is necessary; Risks associated with smallpox vaccination including viral encephalitis, vaccinia...

  • Primary Induction of Human CD8+ Cytotoxic T Lymphocytes and Interferon-Ï’- Producing T Cells after Smallpox Vaccination. Ennis, Francis A.; Cruz, John; Demkowicz Jr., Walter E.; Rothman, Alan L.; McClain, David J. // Journal of Infectious Diseases;6/1/2002, Vol. 185 Issue 11, p1657 

    This study measured the ability of a standard smallpox vaccine, given by scarification (by bifurcated needle), to induce primary human vaccinia virus--specific cytotoxic and interferon (IFN)--γ--producing T lymphocyte responses. Because protection against smallpox may be mediated in part by T...

  • Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Pütz, Mike M.; Midgley, Claire M.; Law, Mansun; Smith, Geoffrey L. // Nature Medicine;Nov2006, Vol. 12 Issue 11, p1310 

    Smallpox was eradicated without an adequate understanding of how vaccination induced protection. In response to possible bioterrorism with smallpox, the UK government vaccinated ∼300 health care workers with vaccinia virus (VACV) strain Lister. Antibody responses were analyzed using ELISA...

  • Smallpox Vaccination: Implementation of National Program Faces Challenges: GAO-03-578.  // GAO Reports;4/30/2003, p1 

    Amid growing concerns about a potential smallpox attack, the Centers for Disease Control and Prevention (CDC) is working with 62 state, local, and territorial jurisdictions to implement the civilian part of the National Smallpox Vaccination Program. The goal is to increase the nation's response...

  • Smallpox vaccine.  // Reactions Weekly;3/13/2004, Issue 992, p13 

    Discusses case reports on the occurrence of secondary or tertiary transfer of vaccinia virus infection following the patients' exposure to smallpox vaccines. Reference to an article published in the February 2004 issue of the "Morbidity and Mortality Weekly Report"; Details of the transmission...

  • VACCINIA VIRUS INFECTION.  // Zoonoses & Communicable Diseases Common to Man & Animals;2003, Vol. 1-3, p330 

    The article offers information on vaccinia virus infection, a disease caused by vaccinia virus, a DNA genome virus belonging to the genus Orthopoxvirus, family Poxviridae. Vaccinia infection resulting from smallpox vaccination can be transmitted from a vaccinee's unhealed vaccination site to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics